Skip to main content
letter
. 2017 Jul 31;19(9):1279–1280. doi: 10.1093/neuonc/nox107

Table 1.

Survival endpoints

International DIPG Registry Patients
n Median (mo) 6 Months 9 Months 12 Months
OS 372 11.2 86.6% 66.1% 45.3%
PFS 372 7.0 58.0% 35.6% 19.2%
OS − PFS 372 2.3 25.0% 13.8% 7.6%
TTP 235 7.0 50.2% 25.8% 12.4%
OS − TTP 235 4.8 38.2% 21.0% 11.6%